Delivery Order SPE2DB20D7061-SPE2DB25FSNG6

Award Date 5/23/25
Potential Completion Date 5/27/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $9,545.94 and a period of performance through April 8, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product, with a total ceiling value of $12,149.99. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it has an ultimate completion date of February 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,228.50 and a completion date of February 4, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,392.11, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product. It is a firm fixed price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,782.05, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of January 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $10,308.48. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $5,078.22 and runs through April 8, 2025. It is a firm fixed price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $9,811.62 and a period of performance through January 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,147.42, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has a ceiling value of $4,336.58 and a completion date of March 5, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB25FSNG6
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $9,659.36. The contract type is a Delivery Order with a Firm Fixed Price pricing model, and the ultimate completion date is May 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/22/25, 9:56 AM